Douglas A. Stewart, MD, FRCPC - Internal Medicine, Medical Oncology

Dr. Douglas Stewart reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Stewart is a professor in the departments of Medicine and Oncology, Divisions of Medical Oncology, Hematology, and Hematological Malignancies, at the University of Calgary in Alberta. He is also a medical oncologist in the Department of Medicine at the Tom Baker Cancer Centre and The Calgary Health Region.

Board Certifications

Specialist Certificate in Medical Oncology
FRCPC Internal Medicine

Healthwise Knowledgebase Topics Reviewed

Non-Hodgkin's Lymphoma
Breast Cancer
Breast Cancer, Metastatic or Recurrent
Inflammatory Breast Cancer


MD: With Distinction, University of Alberta, Edmonton, AB, 1987
FRCPC: Internal Medicine, Medical Oncology Certification, University of Ottawa, Ottawa, ON, 1993
Fellowship: Bone Marrow Transplantation and Lymphoma, University of Nebraska, Omaha, NE, 1994

Academic Appointments

Professor, Departments of Oncology and Medicine, University of Calgary

Hospital Affiliations

Tom Baker Cancer Centre
The Calgary Health Region

Professional Affiliations

Royal College of Physicians and Surgeons of Canada
Canadian Medical Protective Association
Canadian Association of Medical Oncologists
Canadian Hematology Society
American Society of Clinical Oncology
European Bone Marrow Transplant Registry
American Society of Hematology

Selected Publications

  1. Russell J, Savoie M L, Balogh A, Turner A R, Larratt L, Chaudhry M A, Storek J, Bahlis N, Brown C, Quinlan D, Geddes M, Stewart D (2007) Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total body irradiation, and thymoglobulin. Biology of Blood and Marrow Transplantation, 13(7): 814–821.
  2. Stewart DA, Bahlis N, Valentine K, Balogh A, Savoie L, Morris DG, Jones A, Brown C, Russell JA (2006). Upfront double high dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor prognosis aggressive non-Hodgkin’s lymphoma. Blood, 107(12): 4623–4627.
  3. Stewart DA, Paterson AHG, Ruether JD, Russell J, Craighead P, Smylie M, Mackey J (2005). High dose mitoxantrone-vinblastine-Cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: Final results of a prospective, multicentre study. Annals of Oncology, 16(9): 1463–1468.
  4. Conner-Spady BL, Cumming C, Nabholtz J-M, Jacobs P, Stewart D (2005). A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation. Bone Marrow Transplantation, 36(3): 251–259.
  5. Thirukkumaran CM, Luider JM, Stewart, DA, Cheng T, Lupichuk SM, Nodwell MJ, Russell JA, Auer IA, Morris DM (2003). Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation. Blood, 102(1): 377–387.

Financial Disclosure

Dr. Stewart has received grants from the Alberta Cancer Foundation, Hoffmann-La Roche, National Cancer Institute of Canada, Health Canada Best Practices Contribution Program, Calgary Laboratory Services, and GlaxoSmithKline.

related physicians

related services

Bon Secours International| Sisters of Bon Secours USA| Bon Secours Health System

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Privacy Policy. How this information was developed to help you make better health decisions.

© 1995-2010 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.